On the 19th, Alteogen Biologics, a subsidiary of Alteogen, announced that its MENA region partner, SPIMACO, has received product approval for ALT-L9 from the Saudi Food and Drug Authority (SFDA)

Eyluxvi (aflibercept biosimilar) - Alteogen, Biolitec, Hanlim Pharma

Jun 19, 2026